Alzheimer's Disease Anti‐Inflammatory Prevention Trial: Design, methods, and baseline results-Reference-Cited by-同舟云学术

Alzheimer's Disease Anti‐Inflammatory Prevention Trial: Design, methods, and baseline results

Published:2009-03 Issue:2 Volume:5 Page:93-104
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Funder

National Institutes of Health

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2008.09.004

Reference46 articles.

1. About a peculiar disease of the cerebral cortex [translated by L. Jarvik and H. Greenson];Alzheimer A.;Alzheimer Dis Assoc Disord,1987

2. Deaths: leading causes for 2000;Anderson R.N.;Natl Vital Stat Rep,2002

3. Forecasting the global burden of Alzheimer's disease

4. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

5. Double placebo design in a prevention trial for Alzheimer's disease

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Imaging of Neuroinflammation in Alzheimer’s Disease and Mild Cognitive Impairment;Advances in Experimental Medicine and Biology;2023

2. APOE ε4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain;Current Research in Translational Medicine;2023-01

3. Exploring the dual character of metformin in Alzheimer's disease;Neuropharmacology;2022-04

4. Adjudicating Mild Cognitive Impairment Due to Alzheimer’s Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial;The Journal of Prevention of Alzheimer's Disease;2022

5. The contribution of inflammation to Alzheimer's disease in Down syndrome;The Neurobiology of Aging and Alzheimer Disease in Down Syndrome;2022